Copanlisib
Copanlisib is a potent and selective PI3K inhibitor used in research to study tumor growth and survival mechanisms. It is applied in both in vitro and in vivo studies to investigate oncology, signal transduction, and resistance mechanisms in various cancers, including lymphomas.
Product Specifications
CAS Number
1032568-63-0
Product Name Alternative
Inhibit, intravenous, Inhibitor, Apoptosis, antitumor, antiproliferative, BAY 80-6946, administration, AKT, Copanlisib, sub-nanomolar, Phosphoinositide 3-kinase, PI3Kγ, PI3Kδ, PI3Kβ, PI3Kα, phosphorylation, PI3K
Field of Research
Cell Biology, Pharmacology & Drug Discovery, Signal Transduction
Purity
99.00% (May vary between batches)
Solubility
DMSO:< 1 mg/mL (insoluble or slightly soluble) ;1M HCl:71.43 mg/mL (148.65 mM) ;0.01M HCl:10 mg/mL (20.81 mM) ; H2O:Insoluble
Smiles
O (C) C1=C2C (C=3N (C (NC (=O) C=4C=NC (N) =NC4) =N2) CCN3) =CC=C1OCCCN5CCOCC5
Molecular Formula
C23H28N8O4
Molecular Weight
480.52
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
H00009733-P01-10ug 10 µg
Recombinant Human SART3 Protein - (Dry Ice)
Sign In for Pricing
View Details